MASTERINVEST Kapitalanlage GmbH Invests $7.50 Million in CME Group Inc. $CME

MASTERINVEST Kapitalanlage GmbH bought a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 33,967 shares of the financial services provider’s stock, valued at approximately $7,501,000.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. Whipplewood Advisors LLC raised its position in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership acquired a new position in CME Group during the 4th quarter valued at approximately $27,000. Hilton Head Capital Partners LLC purchased a new position in shares of CME Group in the fourth quarter worth $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of CME Group during the second quarter worth $28,000. Finally, Legacy Wealth Managment LLC ID grew its holdings in shares of CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Down 0.0%

Shares of CME opened at $280.94 on Friday. The company has a market capitalization of $101.02 billion, a price-to-earnings ratio of 23.83, a PEG ratio of 3.34 and a beta of 0.23. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The stock’s 50-day moving average price is $253.01 and its 200-day moving average price is $279.09. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The business had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business’s revenue was up .8% on a year-over-year basis. During the same quarter last year, the company earned $2.96 EPS. On average, sell-side analysts predict that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be given a dividend of $1.30 per share. This represents a $5.20 annualized dividend and a yield of 1.9%. The ex-dividend date is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Insider Buying and Selling

In other news, Director William R. Shepard acquired 325 shares of the firm’s stock in a transaction on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the completion of the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.30% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on CME shares. Piper Sandler cut their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 15th. TD Cowen cut their price target on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Weiss Ratings cut shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Tuesday, August 11th. UBS Group dropped their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. Finally, Rothschild & Co Redburn upgraded shares of CME Group from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $316.00 to $323.00 in a research note on Thursday, June 11th. Nine equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and an average price target of $288.56.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.